Riociguat for the treatment of inoperable CTEPH or persistent/recurrent PH after pulmonary endarterectomy (PEA): A responder analysis from the phase III CHEST-1 study - Research portal of Justus Liebig University Giessen:

Meeting Abstract

Riociguat for the treatment of inoperable CTEPH or persistent/recurrent PH after pulmonary endarterectomy (PEA): A responder analysis from the phase III CHEST-1 study

Authors list: D'Armini, Andrea M.; Ghofrani, Hossein-Ardeschir; Kim, Nick H.; Mayer, Eckhard; Simonneau, Gerald; Wilkins, Martin R.; Pulido, Tomas; Fritsch, Arno; Davie, Neil; Hoeper, Marius M.

Publication year: 2013

Journal: European Respiratory Journal

Volume number: 42

ISSN: 0903-1936

eISSN: 1399-3003

Publisher: European Respiratory Society

Citation Styles

Harvard Citation style: D'Armini, A., Ghofrani, H., Kim, N., Mayer, E., Simonneau, G., Wilkins, M., et al. (2013) Riociguat for the treatment of inoperable CTEPH or persistent/recurrent PH after pulmonary endarterectomy (PEA): A responder analysis from the phase III CHEST-1 study, European Respiratory Journal, 42

APA Citation style: D'Armini, A., Ghofrani, H., Kim, N., Mayer, E., Simonneau, G., Wilkins, M., Pulido, T., Fritsch, A., Davie, N., & Hoeper, M. (2013). Riociguat for the treatment of inoperable CTEPH or persistent/recurrent PH after pulmonary endarterectomy (PEA): A responder analysis from the phase III CHEST-1 study. European Respiratory Journal. 42.

Keywords

Pulmonary hypertension; Treatments